This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor: I am sending you this report in response to your request.
The Food and Drug Administration's hearings, "in the matter of hydrocortisone and hydrocortisone acetate ointments and lotions, exemption from prescription-dispensing requirements,'' were held from Aug. 15 to Aug. 17, 1956, in the Health, Education and Welfare Building in Washington, D. C. These hearings reflected the democratic process of this country operating at its very best. The hearings were open to the public, and anybody, with the necessary credentials, could testify or cross examine witnesses. Mr. Leonard D. Hardy, Hearing Examiner, conducted the hearings with great fairness and ingenuity. He stated that such hearings have not been held before and that the rules of procedure would have to be developed as the hearings proceeded. In any case, anybody could talk at any length— but under oath. One prominent figure of the hearings was Mr. Alvin L.
Rothman S. SHOULD TOPICAL HYDROCORTISONE PREPARATIONS BE SOLD WITHOUT PRESCRIPTION? AMA Arch Derm. 1957;75(2):272–273. doi:10.1001/archderm.1957.01550140116024
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: